Navigation Links
Saladax Biomedical, Inc. Completes $9 Million Debt Financing With GE Capital
Date:6/21/2011

BETHLEHEM, Pa., June 21, 2011 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today the completion of a $9 million debt financing with GE Capital.  

The secured term loan facility will be used for commercialization of the company's My5-FU™ assay, the first of Saladax's innovative dose management tests commercially available in the European Union (EU) and Australia as a convenient diagnostic kit that measures levels of 5-flourouracil, a widely used chemotherapy drug administered in conjunction with other drugs in therapy for colorectal cancer and other solid tumors.  The funds will also be used for further development of the company's additional assays.

"We are pleased to welcome GE Capital as an investor in the company," said Edward L. Erickson, president and CEO of Saladax.  "This loan facility will enable Saladax to continue developing and commercializing novel diagnostic products to achieve the promise of personalized medicine today."

Peter Gibson, vice president at GE Capital, Healthcare Financial Services – Life Science Finance, said, "Given that drug optimization through dose management has not been prevalent in oncology, we're delighted to invest in Saladax as the company has already achieved tangible results in this area.  We look forward to working with the Saladax as it continues expanding into additional markets worldwide."

About Saladax Biomedical, Inc.

Saladax Biomedical develops and commercializes novel diagnostic assays to achieve the promise of personalized medicine through dose management and companion diagnostic products for existing and new therapeutics.  The Company's dose management technology enables physicians to optimize drug dosing to meet individual patient needs, leading to improved response an
'/>"/>

SOURCE Saladax Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
2. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
3. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
4. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
5. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Encision Inc. (OTCQB:ECIA), a medical device company ... burns in minimally invasive surgery, today announced financial results ... 2014. The Company posted quarterly net revenue ... $414 thousand, or $(0.04) per share. These results compare ... loss of $50 thousand, or $(0.01) per share, in ...
(Date:10/31/2014)... , Oct. 30, 2014 Electronic ... electronic transmission of prescription related information between ... system allows a physician and nurse practitioner ... a medication error occurs during pharmacy operations. ... applications. It provides complete medical lists, conducts ...
(Date:10/30/2014)... , Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... company that designs, manufactures and markets innovative therapeutic ultrasonic ... announced today that it will report financial results for ... 6, 2014. The Company has scheduled a conference call ... pm ET to review the results. ...
Breaking Medicine Technology:Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2
... Resources, one of the world,s leading research and ... that, in 2008, human epidermal growth factor receptor ... Herceptin and GlaxoSmithKline/Nippon Kayaku,s Tykerb/Tyverb -- were the ... uptake of Herceptin and Tykerb/Tyverb and the expected ...
... -- Chindex International, Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent ... of China, today,announced results for the second quarter and first half ... Financial Highlights:, -- Revenue in the second ... a year over year basis;, ...
Cached Medicine Technology:Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11
(Date:10/31/2014)... 2014 Radiology and EMR Integration ... difference between diagnostic imaging centers but Connectivity is ... DigitalOne. “Differentiation is critical in all businesses ... you consider the intense competition and the downward ... will stand-out from the competition by fully integrating ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Carving pumpkins and ... send many children to emergency rooms in the United ... holidays, Halloween had the fifth highest number of ER ... to 2007-2013 data from the National Electronic Injury Surveillance ... involved the head, noted the American Academy of Orthopaedic ...
(Date:10/31/2014)... of Health will facilitate communication among scientists, clinicians, ... from diagnosis to treatment. The Research Domain Criteria ... Institute of Mental Health (NIMH), part of NIH, ... initiative. , The aim of the RDoC ... that translates basic science into clinical settings by ...
(Date:10/31/2014)... News) -- A comparison of two of the most ... gastric bypass helped patients shed more excess pounds than ... short-term complications and long-term hospitalizations. Gastric-bypass surgery makes ... your body does not absorb all the calories from ... Health. Gastric banding is a type of weight-loss procedure ...
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, 2014 (HealthDay ... of broken bones and injured joints, a new study reports. ... percent of people who had an eczema flare-up in the past ... percent had an injury that caused a limitation of function. ... had more than double the risk of having had a fracture ...
Breaking Medicine News(10 mins):Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2Health News:Halloween at the ER Is No Treat 2Health News:NIMH creates new unit to support its research domain criteria initiative 2Health News:Study Compares 2 Common Weight-Loss Surgeries 2Health News:Study Compares 2 Common Weight-Loss Surgeries 3Health News:Eczema Tied to Bone Fracture Risk in Study 2
... Jan. 13 (HealthDay News) -- Two extra steps may improve ... , A Pap smear is the standard test, but findings ... of the National Cancer Institute call for patients to ... after the Pap smear if they have HPV infections. , ...
... shows value of exercise in treating peripheral arterial disease , , ... that a planned program of walking is good for people ... should check the results of a new U.S. government-funded study. ... of whom didn,t have the pain that is the classic ...
... suggests , , TUESDAY, Jan. 13 (HealthDay News) -- Women calling ... to the hospital after an emergency medical services team had ... , It,s not clear why this was the case, but ... heart attacks. In particular, differences in initial symptoms could explain ...
... National Alliance for Caregiving Call on the New Congress ... CaregiversSAN MATEO, Calif., Jan. 13 There are more ... family members and loved ones: an aging or ailing ... spouse with Alzheimer,s, a sibling with a traumatic war ...
... from White,women on a range of worries about workplace, education and ... decade cited by greater,proportions of Black women than White women include: ... (84 % vs. 68 %), -- Unequal pay ... (72% vs. 57%), -- Limited opportunities for job ...
... S&R Communications Group has entered,a strategic partnership with ... for chorea associated with Huntington,s,disease (HD). Xenazine is ... any HD-related symptom. , ... to help Ovation launch,Xenazine," said S&R President Paul ...
Cached Medicine News:Health News:Walking Is Good for Blocked Leg Arteries 2Health News:Women With Heart Attack Symptoms See Delays in Care 2Health News:Women With Heart Attack Symptoms See Delays in Care 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 2Health News:Caregivers Need a Bailout Too! (or 1% for Families) 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 4Health News:Caregivers Need a Bailout Too! (or 1% for Families) 5Health News:Caregivers Need a Bailout Too! (or 1% for Families) 6Health News:YWCA Survey Shows Greater Economic Concerns Among Black Women Than White Women 2
... for optimum patient comfort. The Nylon Finger Trap ... firm grip. ISI Nylon Finger Traps create a ... with the ISI Digi Grip or ISI Advanced ... available in non-sterile packs and come in five ...
... The CMIS Telemetry System is a ... of hospitals which require monitoring and ... facilities are able to monitor patients ... ambulatory transmitters and wireless bedsides. Now, ...
ISI Self-Supporting Arm Table offers the easy accessibility for surgeons, technicians and equipment during upper extremity surgeries....
MagPrep® Streptavidin Beads are encapsulated super-paramagnetic polystyrol particles coated with streptavidin. The beads have a diameter of 1 m and are provided as a stabilized aqueous suspensio...
Medicine Products: